Schisandrol A Suppresses Catabolic Factor Expression by Blocking NF-κB Signaling in Osteoarthritis

Schisandrol A Suppresses Catabolic Factor Expression by Blocking NF-κB Signaling in Osteoarthritis

Schisandrol A possesses pharmacological properties and is used to treat various diseases; however, its effects on osteoarthritis (OA) progression remain unclear. Here, we investigated Schisandrol A as a potential therapeutic agent for OA. In vitro, Schisandrol A effects were confirmed based on the l...

Full description

Bibliographic Details
Main Authors: Seong Jae Han, Jimoon Jun, Seong-il Eyun, Choong-Gu Lee, Jimin Jeon, Cheol-Ho Pan
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Pharmaceuticals
Subjects:
Schisandrol A
cartilage destruction
osteoarthritis
NF-κB
Online Access:https://www.mdpi.com/1424-8247/14/3/241

Similar Items

Similar Items